Chalfont St. Giles, UK and Waltham, MA USA -- 1 October 2012 -- GE Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE) and NetBio, a leading technology provider in the emerging field of rapid DNA analysis, announced today the launch of DNAscan™ Rapid DNA Analysis™ System, a fast, rugged and easy-to-use DNA analysis instrument for forensic applications.
Chalfont St Giles, UK and Waltham, MA USA-- 30 July 2012 -- GE Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE) and NetBio, a leading provider of technologies for the emerging field of Rapid DNA Analysis, announced today an alliance to commercialize new, fast, cost effective and easy-to-use DNA sample collection and analysis products for the forensic market.
business unit
tags
business unit
tags
Chalfont St. Giles, UK, and Shenzhen, China -- 12 June, 2012 -- GE Healthcare, the healthcare business of GE (NYSE: GE), and BGI, the world's largest genomics organization, jointly announced today a pioneering multi-year research collaboration in stem cell science.
business unit
tags
Chalfont St Giles, UK -- 10 May 2012 -- GE Healthcare, the healthcare business of GE (NYSE: GE) announced today that it has completed the acquisition of Xcellerex, Inc., a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry.